Document is current
Any future updates will be listed below
-
Authors
Saghafi, Fatemeh
Zare, Parisa
Hatamizadeh, Nooshin
Malmir, Maryam
Sahebnasagh, Adeleh
-
Funding
Funding for this research was provided by:
This clinical trial was financially supported by Apira Arman Pirouz Iranian pharmaceutical company.
- License Information
-
More Information
Article History
Received: 19 July 2025
Accepted: 20 September 2025
First Online: 21 October 2025
Declarations
:
: Study protocols were approved by the local Ethics Committee of Shahid Sadoughi University of Medical Sciences (Ethics ID: IR.SSU.MEDICINE.REC.1402.179). Following a health-screening questionnaire, all volunteers provided a written informed consent. Before the intervention, study protocol, benefits, and possible side effects were described for patients. Understandable written informed consent was obtained for all patients prior to participation in the study. This trial was performed in accordance with the Declaration of Helsinki and Good Clinical Practice Guidelines.
: Consent for publication was agreed upon in the written consent forms signed by all subjects for publication of identifying information/images in a publication.
: The authors declare no competing interests.
